Stocks Health care BIXT
OTC · Health careBioxytran, Inc (BIXT)
It posted a net loss of $3.5M. At June 30, 2026 it held $177.4K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch BIXT in 60 secondsWhat Bioxytran, Inc does
Bioxytran, Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BIXT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$2.1M | -$0.02 | n/a |
| 2024 | n/a | -$2.4M | -$0.02 | n/a |
| 2023 | n/a | -$4.5M | -$0.03 | n/a |
| 2022 | n/a | -$2.5M | -$0.02 | n/a |
| 2021 | n/a | -$4M | -$0.04 | n/a |
| 2020 | n/a | -$2.5M | -$0.03 | n/a |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Bioxytran, Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026
- August 11, 2026Other event 8-K
- May 15, 2026
- April 15, 2026
- April 1, 2026Late annual report notice NT 10-K
- March 20, 2026
- March 13, 2026
- March 2, 2026Other event 8-K
- February 17, 2026
- February 11, 2026Other event 8-K
Insider trades
What the people running Bioxytran, Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 18, 2025 | Hoberman Alan MDirector | Bought | 210,000 | $126K |
| November 14, 2025 | Utter AndersDirector | Received as pay | 38,588 | $13.5K |
| November 14, 2025 | Conaway Dale HDirector | Received as pay | 38,588 | $13.5K |
| November 14, 2025 | Milanova RadkaDirector | Received as pay | 38,588 | $13.5K |
| November 14, 2025 | Hoberman Alan MDirector | Received as pay | 38,588 | $13.5K |
Who owns BIXT
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
7 insiders reported holding 44,211,731 shares in total, about $932.9K at the last price.
| Holder | Shares |
|---|---|
| Platt DavidCEO, Director, 10% owner | 20,038,903 |
| Soderquist OlaCFO, 10% owner | 14,376,456 |
| Sheikh MichaelCCO, 10% owner | 8,214,720 |
| Hoberman Alan MDirector | 626,207 |
| Conaway Dale HDirector | 379,177 |
| Utter AndersDirector | 372,580 |
| Milanova RadkaDirector | 203,688 |
Questions about BIXT
What does Bioxytran, Inc do?
Bioxytran, Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BIXT.
Is Bioxytran, Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $3.5M.
When did Bioxytran, Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Compare BIXT with
Follow BIXT
Get an email when Bioxytran, Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow BIXT: get an email when it filesWhere the numbers come from
Financial figures are the values Bioxytran, Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.